A specialized imaging approach was able to detect signs of persistent inflammation in the brains of people with multiple…
Articles by Lindsey Shapiro, PhD
Researchers have identified a distinct profile of self-reactive antibodies that appear in the blood years before the first clinical signs…
Ocrevus (ocrelizumab) continued to prevent disability progression among people with relapsing and progressive forms of multiple sclerosis (MS)…
For people recently diagnosed with multiple sclerosis (MS), first-line treatment with Kesimpta (ofatumumab) was associated with a lower…
Ocrevus (ocrelizumab) had similar benefits in Black and Hispanic multiple sclerosis (MS) patients as earlier clinical trials with…
The Swank and Wahls diets, which are used by people with multiple sclerosis (MS), were associated with improvements in…
Treatment with the neuroprotective protein HB-EGF eased inflammation and promoted tissue recovery across various disease stages in a multiple…
Health Canada has approved the commercial use of ETNA-MS, a software-based medical device that uses eye tracking to noninvasively measure…
Almost all of the nearly 700 people with multiple sclerosis (MS) in Italy who responded to a patient survey…
A subset of astrocytes — a type of support cell for the central nervous system — has a form of immune-related…
People with multiple sclerosis (MS) have a twofold higher risk of seizures compared with the general population, according to…
Using antibodies against a viral protein that’s needed for the Epstein-Barr virus (EBV) to invade human cells was found…
The Polish biotechnology company PolTREG plans to launch Phase 2 trials testing its Tregs therapy — the T-cell-based treatment…
The U.S. Food and Drug Administration (FDA) has decided not to approve an application seeking clearance of GA Depot…
The presence in the brain of chronic inflammatory lesions — called paramagnetic rim lesions (PRLs) — in people with…
Bolstered by Phase 2 trial data showing that frexalimab safely reduces the number of brain lesions in people with relapsing…
An intermittent fasting (IF) diet may lead to immune and metabolic alterations that ease…
Measuring levels of nitric oxide metabolites in the blood could be a diagnostic biomarker for multiple…
High-intensity interval training (HIIT) and a longer but more moderate exercise regimen seem to be of similar benefit to…
Geographical proximity to neurologists and multiple sclerosis (MS) speciality care centers is lower for people living in rural regions…
A diet low in wheat was linked to reductions in circulating inflammatory immune cells and improvements in pain-related life quality…
A smartphone application called Floodlight Open may help in tracking areas of function in people with multiple sclerosis (MS),…
Junctions between nerve cells and certain cells called oligodendrocyte precursor cells, or OPCs, in the brain and spinal cord may…
Women with a history of depression around the time they get pregnant are at increased risk of developing autoimmune diseases…
Daily treatment with CNM-Au8 led to sustained improvements in vision and cognition for people with relapsing-remitting multiple sclerosis (RRMS),…
The U.S. Food and Drug Administration (FDA) has cleared a Phase 2 clinical trial to test Kyverna Therapeutics‘ cell-based…
Immune responses against an ancient viral protein called pHERV-W that’s encoded in the human genome are higher in relapsing-remitting…
The presence of damaged myelin — the fatty, protective substance surrounding nerve cells that’s lost in multiple sclerosis…
About three-quarters of multiple sclerosis (MS) patients given an under-the-skin formulation of cladribine had no disease activity or didn’t…
Women who smoked during pregnancy, and their offspring, showed a significantly higher risk of developing multiple sclerosis (MS) in…